Ensemble Docking Approach to Mitigate Pregnane X Receptor-Mediated CYP3A4 Induction Risk

被引:0
|
作者
Chen, Qi [5 ]
Zhou, Xin [1 ]
Rehmel, Jessica [1 ]
Steele, James P. [2 ]
Svensson, Kjell A. [3 ]
Beck, James P. [4 ]
Hembre, Erik J. [5 ]
Hao, Junliang [4 ]
机构
[1] Eli Lilly & Co, Lilly Biotechnol Ctr, Drug Disposit, San Diego, CA 92121 USA
[2] Eli Lilly & Co, Lilly Biotechnol Ctr, Quantitat Biol, San Diego, CA 92121 USA
[3] Eli Lilly & Co, Lilly Biotechnol Ctr, Neurosci Discovery, San Diego, CA 92121 USA
[4] Eli Lilly & Co, Lilly Biotechnol Ctr, Discovery Chem Res & Technol, San Diego, CA 92121 USA
[5] Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA
关键词
INHIBITORS OPTIMIZING POTENCY; SUBTYPE-SELECTIVE AGENTS; POTENTIAL THERAPEUTICS; COACTIVATOR BINDING; CRYSTAL-STRUCTURE; RECENT PROGRESS; PXR; DISCOVERY; COMPLEX; SULFONAMIDES;
D O I
10.1021/acs.jcim.2c01175
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Three structurally closely related dopamine D1 receptor positive allosteric modulators (D1 PAMs) based on a tetrahydroisoquinoline (THIQ) scaffold were profiled for their CYP3A4 induction potentials. It was found that the length of the linker at the C5 position greatly affected the potentials of these D1 PAMs as CYP3A4 inducers, and the level of induction correlated well with the activation of the pregnane X receptor (PXR). Based on the published PXR X-ray crystal structures, we built a binding model specifically for these THIQ-scaffold-based D1 PAMs in the PXR ligand-binding pocket via an ensemble docking approach and found the model could explain the observed CYP induction disparity. Combined with our previously reported D1 receptor homology model, which identified the C5 position as pointing toward the solvent-exposed space, our PXR-binding model coincidentally suggested that structural modifications at the C5 position could productively modulate the CYP induction potential while maintaining the D1 PAM potency of these THIQ-based PAMs.
引用
收藏
页码:173 / 186
页数:14
相关论文
共 50 条
  • [1] Pregnane x receptor-mediated CYP3A4 induction by antibiotics in liver and intestine
    Yasuda, Kazuto
    Komoroski, Bernard
    Strom, Stephen
    Bachman, Kenneth
    Schuetz, Gallagher
    DRUG METABOLISM REVIEWS, 2006, 38 : 58 - 59
  • [2] Alterations of Histone Modifications Contribute to Pregnane X Receptor-Mediated Induction of CYP3A4 by Rifampicin
    Yan, Liang
    Wang, Yiting
    Liu, Jingyang
    Nie, Yali
    Zhong, Xiao-bo
    Kan, Quancheng
    Zhang, Lirong
    MOLECULAR PHARMACOLOGY, 2017, 92 (02) : 113 - 123
  • [3] Induction of human CYP3A4 by huperzine A, ligustrazine and oridonin through pregnane X receptor-mediated pathways
    Zhang, Yi-wen
    Bao, Mei-hua
    Wang, Guo
    Qu, Qiang
    Zhou, Hong-hao
    PHARMAZIE, 2014, 69 (07): : 532 - 536
  • [4] Pregnane X receptor-mediated induction of Cyp3a by black cohosh
    Pang, Xiaoyan
    Cheng, Jie
    Krausz, Kristopher W.
    Guo, De-an
    Gonzalez, Frank J.
    XENOBIOTICA, 2011, 41 (02) : 112 - 123
  • [5] CYP3A4 and pregnane X receptor humanized mice
    Gonzalez, Frank J.
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2007, 21 (04) : 158 - 162
  • [6] Megestrol acetate is a specific inducer of CYP3A4 mediated by human pregnane X receptor
    Chen, Yakun
    Tang, Yong
    Nie, Jeffrey Z.
    Zhang, Yuanqin
    Nie, Daotai
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (06) : 985 - 996
  • [7] Megestrol acetate is a specific inducer of CYP3A4 mediated by human pregnane X receptor
    Yakun Chen
    Yong Tang
    Jeffrey Z. Nie
    Yuanqin Zhang
    Daotai Nie
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 985 - 996
  • [8] Azole antimycotics differentially affect rifampicin-induced pregnane x receptor-mediated CYP3A4 gene expression
    Svecova, Lucie
    Vrzal, Radim
    Burysek, Ladislav
    Anzenbacherova, Eva
    Cerveny, Lukas
    Grim, Jiri
    Trejtnar, Frantisek
    Kunes, Jiri
    Pour, Milan
    Staud, Frantisek
    Anzenbacher, Pavel
    Dvorak, Zdenek
    Pavek, Petr
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (02) : 339 - 348
  • [9] Disabled pregnane X receptor function potentiates constitutive androstane receptor-mediated CYP3A induction
    Konstantinou, DK
    Marek, CJ
    Edwards, RJ
    Hawksworth, GM
    Goodwin, B
    Wright, MC
    TOXICOLOGY, 2005, 213 (03) : 227 - 228
  • [10] CYP3A4 induction by drugs: Correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes
    Luo, G
    Cunningham, M
    Kim, S
    Burn, T
    Lin, JR
    Sinz, M
    Hamilton, G
    Rizzo, C
    Jolley, S
    Gilbert, D
    Downey, A
    Mudra, D
    Graham, R
    Carroll, K
    Xie, JD
    Madan, A
    Parkinson, A
    Christ, D
    Selling, B
    LeCluyse, E
    Gan, LS
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (07) : 795 - 804